Curcumin analogs as the inhibitors of TLR4 pathway in inflammation and their drug like potentialities: a computer-based study

References

• Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011;31(5):986–1000.
   PubMed Web of Science ®Google Scholar
• Liu CH, Abrams ND, Carrick DM, et al. Imaging inflammation and its resolution in health and disease: current status, clinical needs, challenges, and opportunities. FASEB J. 2019;33(12):13085–13097.
   PubMed Web of Science ®Google Scholar
• Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428–435.
   PubMed Web of Science ®Google Scholar
• Lon HK, Liu D, Jusko WJ. Pharmacokinetic/pharmacodynamic modeling in inflammation. Critic Rev Biomed Eng. 2012;40(4):295–312.
   PubMedGoogle Scholar
• Horadagoda NU, Knox KM, Gibbs HA, et al. Acute phase proteins in cattle: discrimination between acute and chronic inflammation. Vet Rec. 1999;144(16):437–441.
   PubMed Web of Science ®Google Scholar
• Lee JW, Lee YK, Yuk DY, et al. Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J Neuroinflammation. 2008;5(1):37.
   PubMed Web of Science ®Google Scholar
• Feghali CA, Wright TM. Cytokines in acute and chronic inflammation. Front Biosci. 1997;2(1):d12–26.
   PubMedGoogle Scholar
• Cox SS, Speaker KJ, Beninson LA, Craig WC, et al. Adrenergic and glucocorticoid modulation of the sterile inflammatory response. Brain Behav Immun. 2014;36:183–192.
   PubMed Web of Science ®Google Scholar
• Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr. 2006;83(2):456S–4560. S.
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–867.
   PubMed Web of Science ®Google Scholar
• Zvaifler NJ. The immunopathology of joint inflammation in rheumatoid arthritis. Adv Immunol. 1973;16:265–336.
   PubMedGoogle Scholar
• Bauer ME, Teixeira AL. Inflammation in psychiatric disorders: what comes first? Ann NY Acad Sci. 2019;1437(1):57–67.
   PubMed Web of Science ®Google Scholar
• Kaczorowski DJ, Nakao A, Vallabhaneni R, et al. Mechanisms of toll-like receptor 4 (TLR4)-mediated inflammation after cold ischemia/reperfusion in the heart. Transplantation. 2009;87(10):1455–1463.
   PubMed Web of Science ®Google Scholar
• Blackwell TS, Christman JW. The role of nuclear factor-κ B in cytokine gene regulation. Am J Respir Cell Mol Biol. 1997;17(1):3–9.
   PubMed Web of Science ®Google Scholar
• Zhang B, Ramesh G, Uematsu S, et al. TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity. J Am Soc Nephrol. 2008;19(5):923–932.
   PubMed Web of Science ®Google Scholar
• Poligone B, Baldwin AS. Positive and negative regulation of NF-κB by COX-2 ROLES OF DIFFERENT PROSTAGLANDINS. J Biol Chem. 2001;276(42):38658–38664.
   PubMed Web of Science ®Google Scholar
• Fitzgerald KA, McWhirter SM, Faia KL, et al. IKKε and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol. 2003;4(5):491–496.
   PubMed Web of Science ®Google Scholar
• Tak PP, Firestein GS. NF-κB: a key role in inflammatory diseases. J Clin Invest. 2001;07(1):7–11.
   Google Scholar
• Zhao P, In Wong K, Sun X, et al. TBK1 at the crossroads of inflammation and energy homeostasis in adipose tissue. Cell. 2018;172(4):731–743.
   PubMed Web of Science ®Google Scholar
• Kishore N, Huynh QK, Mathialagan S, et al. IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2 COMPARATIVE ANALYSIS OF RECOMBINANT HUMAN IKK-i, TBK-1, AND IKK-2. J Biol Chem. 2002;277(16):13840–13847.
   PubMed Web of Science ®Google Scholar
• Yu M, Ives D, Ramesha CS. Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2. J Biol Chem. 1997;272(34):21181–21186.
   PubMed Web of Science ®Google Scholar
• Hasan M, Yan N. Therapeutic potential of targeting TBK1 in autoimmune diseases and interferonopathies. Pharmacol Res. 2016;111:336–342.
   PubMed Web of Science ®Google Scholar
• Burke JR, Pattoli MA, Gregor KR, et al. BMS-345541 is a highly selective inhibitor of IκB kinase that binds at an allosteric site of the enzyme and blocks NF-κB-dependent transcription in mice. J Biol Chem. 2003;278(3):1450–1456.
   PubMed Web of Science ®Google Scholar
• Voilley N, de Weille J, Mamet J, et al. Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors. J Neurosci. 2001;21(20):8026–8033.
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Hayllar J, Dre A, Macpherson NJ, et al. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology. 1993;104(6):1832–1847.
   PubMed Web of Science ®Google Scholar
• Mendes RT, Stanczyk CP, Sordi R, et al. Selective inhibition of cyclooxygenase-2: risks and benefits. Rev Bras Reumatol. 2012;52(5):767–782.
   PubMedGoogle Scholar
• Rao P, Knaus EE. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J Pharm Pharm Sci. 2008;11(2):81–110.
   PubMed Web of Science ®Google Scholar
• Martel-Pelletier J, Lajeunesse D, Reboul P, et al. Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs. Ann Rheum Dis. 2003;62(6):501–509.
   PubMed Web of Science ®Google Scholar
• Payne R. Limitations of NSAIDs for pain management: toxicity or lack of efficacy? The Journal of Pain. 2000;1(3):14–18.
   PubMed Web of Science ®Google Scholar
• Lisowska B, Kosson D, Domaracka K. Positives and negatives of nonsteroidal anti-inflammatory drugs in bone healing: the effects of these drugs on bone repair. Drug Des Devel Ther. 2018;12:1809–1814.
   PubMed Web of Science ®Google Scholar
• De Gaetano G, Donati MB, Cerletti C. Prevention of thrombosis and vascular inflammation: benefits and limitations of selective or combined COX-1, COX-2 and 5-LOX inhibitors. Trends Pharmacol Sci. 2003;24(5):245–252.
   PubMed Web of Science ®Google Scholar
• Asenso J, Yang XD, Yu J, et al. Plant-based anti-inflammatory agents: progress from Africa and China. Clin Anti Inflamm Anti Allergy Drug. 2015;2(1):52–66.
   Google Scholar
• Sarkar B, Ullah MA, Islam MS, et al. Potential of medicinal plants from Bangladesh and their effective compounds against cancer. J Pharm Phytochem. 2019;8(3):827–833.
   Google Scholar
• Maione F, Russo R, Khan H, et al. Medicinal plants with anti-inflammatory activities. Nat Prod Res. 2016;30(12):1343–1352.
   PubMed Web of Science ®Google Scholar
• Goel A, Boland CR, Chauhan DP. Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett. 2001;172(2):111–118.
   PubMed Web of Science ®Google Scholar
• Kohli K, Ali J, Ansari MJ, et al. Curcumin: a natural antiinflammatory agent. Indian J Pharmacol. 2005;37(3):141.
   Google Scholar
• Meng Z, Yan C, Deng Q, et al. Curcumin inhibits LPS-induced inflammation in rat vascular smooth muscle cells in vitro via ROS-relative TLR4-MAPK/NF-κB pathways. Acta Pharmacol Sin. 2013;34(7):901–911.
   PubMed Web of Science ®Google Scholar
• Zhu HT, Bian C, Yuan JC, et al. Curcumin attenuates acute inflammatory injury by inhibiting the TLR4/MyD88/NF-κB signaling pathway in experimental traumatic brain injury. J Neuroinflamm. 2014;11(1):59.
   PubMedGoogle Scholar
• Yuniarti N, Nugroho PA, Asyhar A, et al. In vitro and In Silico Studies on Curcumin and Its Analogues as Dual Inhibitors for cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). ITB J Sci. 2012;44(1):51–66.
   Google Scholar
• Shishodia S, Potdar P, Gairola CG, et al. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-κB activation through inhibition of IκBα kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis. 2003;24(7):1269–1279.
   PubMed Web of Science ®Google Scholar
• Chun KS, Kang JY, Kim OH, et al. Effects of yakuchinone A and yakuchinone В on the Phorbol ester-induced expression of COX-2 and iNOS and activation of NF-kB in mouse skin. J Environ Pathol Toxicol Oncol. 2002;21(2):9.
   Google Scholar
• Simerska P, Moyle PM, Toth I. Modern lipid‐, carbohydrate‐, and peptide‐based delivery systems for peptide, vaccine, and gene products. Med Res Rev. 2011;31(4):520–547.
   PubMed Web of Science ®Google Scholar
• Park SJ, Lee MY, Son BS, et al. TBK1-targeted suppression of TRIF-dependent signaling pathway of Toll-like receptors by 6-shogaol, an active component of ginger. Biosci Biotechnol Biochem. 2009;73(7):1474–1478.
   PubMed Web of Science ®Google Scholar
• Anand P, Thomas SG, Kunnumakkara AB, et al. Activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol. 2008;76(11):1590–1611.
   PubMed Web of Science ®Google Scholar
• Kiuchi F, Goto Y, Sugimoto N, et al. Nematocidal activity of turmeric: synergistic action of curcuminoids. Chem Pharm Bull. 1993;41(9):1640–1643.
   PubMed Web of Science ®Google Scholar
• Kim SO, Kundu JK, Shin YK, et al. [6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-κ B in phorbol ester-stimulated mouse skin. Oncogene. 2005;24(15):2558–2567.
   PubMed Web of Science ®Google Scholar
• Huang WY, Cai YZ, Zhang Y. Natural phenolic compounds from medicinal herbs and dietary plants: potential use for cancer prevention. Nutr Cancer. 2009;62(1):1–20.
   Web of Science ®Google Scholar
• Keum YS, Kim J, Lee KH, et al. Induction of apoptosis and caspase-3 activation by chemopreventive [6]-paradol and structurally related compounds in KB cells. Cancer Lett. 2002;177(1):41–47.
   PubMed Web of Science ®Google Scholar
• Ling H, Yang H, Tan SH, et al. 6‐Shogaol, an active constituent of ginger, inhibits breast cancer cell invasion by reducing matrix metalloproteinase‐9 expression via blockade of nuclear factor‐κB activation. Br J Pharmacol. 2010;161(8):1763–1777.
   PubMed Web of Science ®Google Scholar
• Masuda T, Matsumura H, Oyama Y, et al. Synthesis of (±)-cassumunins A and B, new curcuminoid antioxidants having protective activity of the living cell against oxidative damage. J Nat Prod. 1998;61(5):609–613.
   PubMed Web of Science ®Google Scholar
• Yogosawa S, Yamada Y, Yasuda S, et al. Dehydrozingerone, a structural analogue of curcumin, induces cell-cycle arrest at the G2/M phase and accumulates intracellular ROS in HT-29 human colon cancer cells. J Nat Prod. 2012;75(12):2088–2093.
   PubMed Web of Science ®Google Scholar
• Lin CC, Ho CT, Huang MT. Mechanistic studies on the inhibitory action of dietary dibenzoylmethane, a beta-diketone analogue of curcumin, on 7, 12-dimethylbenz [a] anthracene-induced mammary tumorigenesis. Proc Natl Sci Counc Repub China B. 2001;25(3):158–65.
   Google Scholar
• Fujisawa S, Atsumi T, Ishihara M, et al. Cytotoxicity, ROS-generation activity and radical-scavenging activity of curcumin and related compounds. Anticancer Res. 2004;24(2B):563–570.
   PubMed Web of Science ®Google Scholar
• Flynn DL, Rafferty MF, Boctor AM. Inhibition of 5-hydroxy-eicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally-occurring diarylheptanoids: inhibitory activities of curcuminoids and yakuchinones. Prostaglandins Leukot Med. 1986;22(3):357–360.
   PubMedGoogle Scholar
• Lipinski CA, Lombardo F, Dominy BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 1997;23(1–3):3–25.
   Web of Science ®Google Scholar
• Ullah A, Prottoy NI, Araf Y, et al. Molecular dcking and pharmacological property analysis of phytochemicals from clitoria ternatea as potent inhibitors of cell cycle checkpoint proteins in the cyclin/CDK pathway in cancer cells. Comput Mol Biosci. 2019;09(03):81–94.
   Google Scholar
• Bolton EE, Wang Y, Thiessen PA, et al. PubChem: integrated platform of small molecules and biological activities. Ann Rep Comput Chem. 2008;4:217–241.
   Google Scholar
• Cheminformatics M. Nova ulica, SK-900 26 Slovensky Grob, Slovak Republic [Internet]. Bratislava University; 1986
   Google Scholar
• Lucido MJ, Orlando BJ, Vecchio AJ, et al. Crystal structure of aspirin-acetylated human cyclooxygenase-2: insight into the formation of products with reversed stereochemistry. Biochemistry. 2016;55(8):1226–1238.
   PubMed Web of Science ®Google Scholar
• Xu G, Lo YC, Li Q, et al. Crystal structure of inhibitor of κB kinase β. Nature. 2011;472(7343):325–330.
   PubMed Web of Science ®Google Scholar
• Beyett TS, Gan X, Reilly SM, et al. Carboxylic acid derivatives of amlexanox display enhanced potency toward TBK1 and IKKε and reveal mechanisms for selective inhibition. Mol Pharmacol. 2018;94(4):1210–1219.
   PubMed Web of Science ®Google Scholar
• Schrödinger Release 2018-4: Protein Preparation Wizard; Epik, Schrödinger, LLC, New York (NY): 2016; Impact, Schrödinger, LLC, New York (NY): 2016; Prime, Schrödinger, LLC, New York (NY): 2018.
   Google Scholar
• Kim S, Thiessen PA, Bolton EE, et al. PubChem substance and compound databases. Nucleic Acids Res. 2016;44(D1):D1202–13.
   PubMed Web of Science ®Google Scholar
• Schrödinger Release 2018–4: ligprep, schrödinger. New York (NY): LLC; 2018.
   Google Scholar
• Schrödinger Release 2018–4: glide, schrödinger. New York (NY): LLC; 2018.
   Google Scholar
• Ramírez D, Caballero J. Is it reliable to use common molecular docking methods for comparing the binding affinities of enantiomer pairs for their protein target? Int J Mol Sci. 2016;17(4):525.
   PubMed Web of Science ®Google Scholar
• Dassault Systèmes BIOVIA. Discovery studio visualizer, 19.1. San Diego(CA): Dassault Systèmes; 2019.
   Google Scholar
• Lyne PD, Lamb ML, Saeh JC. Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. J Med Chem. 2006;49(16):4805–4808.
   PubMed Web of Science ®Google Scholar
• Wishart DS, Knox C, Guo AC, et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008;36(1):D901–6.
   PubMedGoogle Scholar
• Zhong H, Tran LM, Stang JL. Induced-fit docking studies of the active and inactive states of protein tyrosine kinases. J Mol Graphics Modell. 2009;28(4):336–346.
   Google Scholar
• Yu H, Adedoyin A. ADME–Tox in drug discovery: integration of experimental and computational technologies. Drug Discov Today. 2003;8(18):852–861.
   PubMed Web of Science ®Google Scholar
• Hossain S, Sarkar B, Prottoy MN, et al. Thrombolytic activity, drug likeness property and ADME/T analysis of isolated phytochemicals from ginger (zingiber officinale) using in silico approaches. Modern Res Inflamm. 2019;8 (03):29–43.
   Google Scholar
• Yang H, Lou C, Sun L, et al. admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties. Bioinformatics. 2019;35(6):1067–1069.
   PubMed Web of Science ®Google Scholar
• Pires DE, Blundell TL, Ascher DB. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. 2015;58(9):4066–4072.
   PubMed Web of Science ®Google Scholar
• Filimonov DA, Lagunin AA, Gloriozova TA, et al. Prediction of the biological activity spectra of organic compounds using the PASS online web resource. Chem Heterocycl Comp. 2014;50(3):444–457.
   Web of Science ®Google Scholar
• Tarcsay Á, Keserű GM. In silico site of metabolism prediction of cytochrome P450-mediated biotransformations. Expert Opin Drug Metab Toxicol. 2011;7(3):299–312.
   PubMed Web of Science ®Google Scholar
• Zaretzki J, Bergeron C, Huang TW, et al. RS-WebPredictor: a server for predicting CYP-mediated sites of metabolism on drug-like molecules. Bioinformatics. 2013;29(4):497–498.
   PubMed Web of Science ®Google Scholar
• Schrödinger release 2018–4: jaguar, schrödinger. New York (NY): LLC; 2018.
   Google Scholar
• Becke AD. A new mixing of Hartree–Fock and local density‐functional theories. J Chem Phys. 1993;98(2):1372–1377.
   Web of Science ®Google Scholar
• Gill PM, Johnson BG, Pople JA, Frisch MJ. The performance of the Becke—Lee—Yang—Parr (B—LYP) density functional theory with various basis sets. Chem Phys Lett. 1992;197(4–5):499–505.
   Web of Science ®Google Scholar
• Stephens PJ, Devlin FJ, Chabalowski CF, et al. Ab initio calculation of vibrational absorption and circular dichroism spectra using density functional force fields. J Phys Chem. 1994;98(45):11623–11627.
   Web of Science ®Google Scholar
• Pearson RG. Absolute electronegativity and hardness correlated with molecular orbital theory. Proc Natl Acad Sci. 1986;83(22):8440–8441.
   PubMed Web of Science ®Google Scholar
• Parr RG, Yang W. International series of monographs on chemistry 16: density-functional theory of atoms and molecules. New York (NY): Oxford University Press; 1989.
   Google Scholar
• Tian S, Wang J, Li Y, et al. The application of in silico drug-likeness predictions in pharmaceutical research. Adv Drug Delivery Rev. 2015;86:2–10.
   PubMed Web of Science ®Google Scholar
• Sarkar B, Islam SS, Ullah MA, et al. Computational assessment and pharmacological property breakdown of eight patented and candidate drugs against four intended targets in Alzheimer’s disease. Adv Biosci Biotechnol. 2019;10(11):405–430.
   Google Scholar
• Gschwend DA, Good AC, Kuntz ID. Molecular docking towards drug discovery. J Mol Recognit. 1996;9(2):175–186.
   PubMed Web of Science ®Google Scholar
• Prottoy NI, Sarkar B, Ullah A, et al. Molecular docking and pharmacological property analysis of antidiabetic agents from medicinal plants of Bangladesh against type II diabetes: a computational approach. PharmTutor. 2019;7(9):6–15.
   Google Scholar
• Shoichet BK, McGovern SL, Wei B, et al. Lead discovery using molecular docking. Curr Opin Chem Biol. 2002;6(4):439–446.
   PubMed Web of Science ®Google Scholar
• Sarkar B, Ullah MA, Islam SS. In silico analysis of some phytochemicals as potential anti-cancer agents targeting cyclin dependent kinase-2, human topoisomerase IIa and vascular endothelial growth factor receptor-2. bioRxiv. Cold Spring Harbor (NY); 2020.
   Google Scholar
• Sun H, Li Y, Tian S, et al. Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set. Phys Chem Chem Phys. 2014;16(31):16719–16729.
   PubMed Web of Science ®Google Scholar
• Tripathi A, Bankaitis VA. Molecular docking: from lock and key to combination lock. J Mol Med Clin Appl. 2017;2(1):10.16966/2575-0305.106.
   PubMedGoogle Scholar
• Davis AM, Teague SJ. Hydrogen bonding, hydrophobic interactions, and failure of the rigid receptor hypothesis. Angew Chem Int Ed. 1999;38(6):736–749.
   PubMed Web of Science ®Google Scholar
• Garavito RM, DeWitt DL. The cyclooxygenase isoforms: structural insights into the conversion of arachidonic acid to prostaglandins. Biochim Biophys Acta. 1999;1441(2–3):278–287.
   PubMed Web of Science ®Google Scholar
• Yu T, Yi YS, Yang Y, et al. The pivotal role of TBK1 in inflammatory responses mediated by macrophages. Med Inflamm. 2012;2012:1–8.
   Web of Science ®Google Scholar
• Wang Y, Xing J, Xu Y, et al. In silico ADME/T modelling for rational drug design. Quart Rev Biophys. 2015;48(4):488–515.
   PubMed Web of Science ®Google Scholar
• Paul Gleeson M, Hersey A, Hannongbua S. In-silico ADME models: a general assessment of their utility in drug discovery applications. Curr Top Med Chem. 2011;11(4):358–381.
   PubMed Web of Science ®Google Scholar
• Li AP. Screening for human ADME/Tox drug properties in drug discovery. Drug Discov Today. 2001;6(7):357–366.
   PubMed Web of Science ®Google Scholar
• Geerts T, Vander Heyden Y. In silico predictions of ADME-tox properties: drug absorption.  Combinat Chem High Throughput Screen. 2011;14(5):339–361.
   PubMed Web of Science ®Google Scholar
• Anzenbacher P, Anzenbacherova E. Cytochromes P450 and metabolism of xenobiotics. Cmls, Cell Mol Life Sci. 2001;58(5):737–747.
   PubMed Web of Science ®Google Scholar
• Lamb DC, Waterman MR, Kelly SL, et al. Cytochromes P450 and drug discovery. Curr Opin Biotechnol. 2007;18(6):504–512.
   PubMed Web of Science ®Google Scholar
• De Graaf C, Vermeulen NP, Feenstra KA. Cytochrome P450 in silico: an integrative modeling approach. J Med Chem. 2005;48(8):2725–2755.
   PubMed Web of Science ®Google Scholar
• Ames BN, Gurney EG, Miller JA, et al. Carcinogens as frameshift mutagens: metabolites and derivatives of 2-acetylaminofluorene and other aromatic amine carcinogens. Proc Natl Acad Sci. 1972;69(11):3128–3132.
   PubMed Web of Science ®Google Scholar
• Xu C, Cheng F, Chen L, et al. In silico prediction of chemical Ames mutagenicity. J Chem Inf Model. 2012;52(11):2840–2847.
   PubMed Web of Science ®Google Scholar
• Priest B, Bell IM, Garcia M. Role of hERG potassium channel assays in drug development. Channels. 2008;2(2):87–93.
   PubMed Web of Science ®Google Scholar
• Hacker K, Maas R, Kornhuber J, et al. Substrate-dependent inhibition of the human organic cation transporter OCT2: a comparison of metformin with experimental substrates. PLoS One. 2015;10(9):e0136451.
   PubMed Web of Science ®Google Scholar
• Stepanchikova AV, Lagunin AA, Filimonov DA, et al. Prediction of biological activity spectra for substances: evaluation on the diverse sets of drug-like structures. Curr Med Chem. 2003;10(3):225–233.
   PubMed Web of Science ®Google Scholar
• Lagunin A, Stepanchikova A, Filimonov D, et al. PASS: prediction of activity spectra for biologically active substances. Bioinformatics. 2000;16(8):747–748.
   PubMed Web of Science ®Google Scholar
• Overington JP, Al-Lazikani B, Hopkins AL. How many drug targets are there? Nat Rev Drug Discov. 2006;5(12):993–996.
   PubMed Web of Science ®Google Scholar
• Lundstrom K. An overview on GPCRs and drug discovery: structure-based drug design and structural biology on GPCRs. Methods Mol Biol. 2009;552:51–66.
   Google Scholar
• Mainardes RM, Silva LP. Drug delivery systems: past, present, and future. Curr Drug Targets. 2004;5(5):449–455.
   PubMed Web of Science ®Google Scholar
• Zhan CG, Nichols JA, Dixon DA. Ionization potential, electron affinity, electronegativity, hardness, and electron excitation energy: molecular properties from density functional theory orbital energies. J Phys Chem A. 2003;107(20):4184–4195.
   Web of Science ®Google Scholar
• Becke AD. Density-functional exchange-energy approximation with correct asymptotic behavior. Phys Rev A. 1988;38(6):3098–3100.
   PubMed Web of Science ®Google Scholar
• Young HY, Luo YL, Cheng HY, Hsieh WC, et al. Analgesic and anti-inflammatory activities of [6]-gingerol. J Ethnopharmacol. 2005;96(1–2):207–210.
   PubMed Web of Science ®Google Scholar
• Chun KS, Park KK, Lee J, et al. Inhibition of mouse skin tumor promotion by anti-inflammatory diarylheptanoids derived from Alpinia oxyphylla Miquel (Zingiberaceae). Oncol Res. 2002;13(1):37–45.
   PubMed Web of Science ®Google Scholar